Pharmacy Medical News about Patient awareness, Bladder cancer, Smoking, Risk factor

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Patient awareness of smoking as a risk factor for bladder cancer
International Urology and Nephrology, 07/16/09

Anastasiou I et al. - Urological patients’ awareness of smoking as a risk factor for bladder cancer is lower than that for other smoking-related entities. It is recommended that urologist should also include counseling these patients on the need for radical changes of their life style.

Methods

Aim was to determine urological pts’ awareness of smoking as a risk factor for bladder cancer
202 consecutive urological inpatients, using a structured questionnaire
Urological pts’ awareness of smoking as a risk factor for bladder cancer and other smoking-related pathologies was evaluated
Smoker-bladder cancer pts were asked whether:
- They believed that smoking was related to their present bladder problem
- Their treating urologist had ever advised them on the same, and
- Whether they intended to quit

Results

58.4% of pts stated that they were aware of smoking as a risk factor for bladder cancer, as apposed to:
- 94.6% for chronic obstructive pulmonary disease
- 91.6% for heart and vascular problems, and
- 92.1%, for lung cancer
Perception was unrelated to age, gender, smoking habits, or history of heart or chronic lung disease
Of current smokers/TCC pts, 56.4% believed that smoking is related to their problem and 61.5% intended to quit
84.6% of pts had been already warned by their attending physicians

<< Previous
Stabilized Infective Endocarditis and Altered Heparin...

Next >>
Clinical and resource-use outcomes of risperidone long-acting...